$SPPI

Spectrum Pharmaceuticals Inc.

  • NASDAQ
  • Health Technology
  • Biotechnology

PRICE

$3.9 ▼-0.256%

Extented Hours

VOLUME

3,256,155

DAY RANGE

3.55 - 3.95

52 WEEK

1.74 - 10.57

Echofin Members Consensus

SO
soheil.n #StockTraders.NET Join team
recently

i waited too long for $sppi for a bounce that never came...seeing a trend recently some just don't bounce

profile
maletone #StockTraders.NET Join team
recently

yup i wanted $SPPI too

BR
brAli #StockTraders.NET Join team
recently

i reall wanted tht $sppi to pop HOD

Key Metrics

Market Cap

448.86 M

Beta

1.21

Avg. Volume

3.25 M

Shares Outstanding

114.80 M

Yield

0%

Public Float

112.30 M

Next Earnings Date

2020-08-10

Next Dividend Date

Company Information

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.

CEO: Joseph W. Turgeon

Website:

HQ: 11500 South Eastern Avenue Henderson, 89052 NV

Related News

  • Business Wire

    Spectrum Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Corporate Update

    03 Aug 2020, 11:00
  • Business Wire

    Spectrum Pharmaceuticals Announces Pricing of Public Offering of Common Stock

    30 Jul 2020, 11:00
  • Seeking Alpha

    TCOM, PII among premarket gainers

    28 Jul 2020, 12:16
  • Smarter Analyst

    Spectrum Pops 71% In After-Hours On ‘Positive’ Data For Lung Cancer Treatment

    28 Jul 2020, 07:32
  • Business Wire

    Spectrum Pharmaceuticals Announces Positive Topline Results in HER2 Exon20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Trial

    27 Jul 2020, 20:00